Atrium Therapeutics is a biopharmaceutical company pioneering the delivery of precision RNA therapeutics to the heart to transform cardiac care. Headquartered in San Diego, California, the newly independent and publicly traded company launched in February 2026.
Subscribe to see Atrium Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atrium Therapeutics, Inc. is a healthcare company headquartered in San Diego, United States. It is publicly listed (RNA) with a market capitalisation of $130.2M. Xcout tracks 16 named people at Atrium Therapeutics, Inc., including Kathleen Gallagher (President, CEO & Director). Xcout recorded 10 job postings from Atrium Therapeutics, Inc. in the last 90 days.
10 more named people on record for Atrium Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Xcout recorded 10 job postings from Atrium Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Atrium Therapeutics, Inc.'s hiring signals →
A few of Atrium Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Airway Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel biologic therapies for respiratory and other diseases. The company is headquartered in Atlanta, Georgia.
ACEA Therapeutics, Inc. is a biopharmaceutical company committed to improving healthcare and treatments, headquartered in San Diego, California.
CircNova is a private biotechnology company founded in 2023 with headquarters in Detroit, Michigan, specializing in the development of RNA-based therapeutics.
Ausperbio is a clinical-stage biopharmaceutical company dedicated to transforming hepatitis B virus (HBV) treatment for a cure and advancing oligonucleotide therapeutics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Atrium Therapeutics, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.